R. CIFTCI Et Al. , "Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.," 50th Annual Meeting of the American-Society-of-Clinical-Oncology , vol.32, Illinois, United States Of America, 2014
CIFTCI, R. Et Al. 2014. Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.. 50th Annual Meeting of the American-Society-of-Clinical-Oncology , (Illinois, United States Of America).
CIFTCI, R., Tas, F., AKSIT, E., Vatansever, S., KARABULUT, S., Sen, F., ... YILDIZ, I.(2014). Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer. . 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America
CIFTCI, Rumeysa Et Al. "Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.," 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 2014
CIFTCI, Rumeysa Et Al. "Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America, 2014
CIFTCI, R. Et Al. (2014) . "Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Rumeysa ÇİFTÇİ Et Al. }, title={Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.}, congress name={50th Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Illinois}, country={United States Of America}, year={2014}}